Search For "biopharmaceutical"
Glenmark Pharma reports revenue of Rs 27,773 Mn and PAT of Rs 2,111 Mn for
Updated : 3 years, 7 months ago IST
Mumbai (Maharashtra) [India], August 11 (ANI/PRNewswire): Glenmark Pharmaceuticals Ltd. (Glenmark), an innovation-driven global pharmaceutical company, today announced its financial results for the first quarter ended June 30, 2022.
Read More
Frontier Biotechnologies announces positive phase 1 results of its first c
Updated : 3 years, 7 months ago IST
Atlanta (Georgia) [US], August 10 (ANI/PRNewswire): Frontier Biotechnologies, a biopharmaceutical company focused on the discovery, development and dissemination of innovative medicines that improve patient health, announced positive results from the Phase 1 clinical trial of its drug candid
Read More
NTAGI to discuss data of Gennova pharmaceuticals' indigenous mRNA vaccine
Updated : 3 years, 8 months ago IST
New Delhi [India], July 11 (ANI): The National Technical Advisory Group on Immunisation (NTAGI's) Covid working group is expected to conduct a meeting soon to discuss India's first mRNA vaccine against COVID and Biological E's Corbevax Booster dose for Covishield and Covaxin beneficiaries
Read More
Glenmark launches sitagliptin and its fixed-dose combinations, at affordab
Updated : 3 years, 8 months ago IST
Mumbai (Maharashtra) [India], July 8 (ANI/PRNewswire): Glenmark Pharmaceuticals Limited (Glenmark), an innovation-driven global pharmaceutical company has launched sitagliptin and its Fixed Dose Combinations (FDCs), at affordable prices for adults with Type 2 diabetes in India. The company h
Read More
If govt permits indigenous mRNA vaccine is ready to be roll out in 72 hou
Updated : 3 years, 8 months ago IST
New Delhi [India], June 29 (ANI): The company is ready to roll out India's first mRNA vaccine in 72 hours after the government's permission, said Gennova Biopharmaceuticals Ltd Chief Executive Officer and Whole-time Director Dr Sanjay Singh.
Read More
India's first mRNA vaccine by Gennova gets DCGI approval, to be rolled out
Updated : 3 years, 8 months ago IST
Pune (Maharashtra) [India], June 29 (ANI): India's first indigenously developed mRNA vaccine against the COVID-19 gets the Emergency Use Authorization (EUA), to be sold under the brand name GEMCOVAC™-19 and will be rolled out soon, informed the officials on Wednesday.
Read More
DCGI gives emergency use authorisation to India's first mRNA COVID-19 vacc
Updated : 3 years, 8 months ago IST
New Delhi [India], June 28 (ANI): The Drugs Controller General of India (DCGI) has approved two doses of Pune-based Gennova Biopharmaceuticals' mRNA COVID-19 vaccine for restricted use in emergency situations for beneficiaries aged above 18 years age group.
Read More
A. Menarini expands its dermatology portfolio with the launch of Solar D&#
Updated : 3 years, 9 months ago IST
New Delhi [India], May 27 (ANI/BusinessWire India): A. Menarini India Private Limited ("Menarini India"), part of the Menarini Group, the world's largest Italian biopharmaceutical company, announces the launch of 'Solar D®' sunscreen - a breakthrough innovation in dermatology in over 70
Read More
CDL Kasauli clears over 21 lakh mRNA COVID-19 vaccine doses: Sources
Updated : 3 years, 10 months ago IST
New Delhi [India], May 13 (ANI): The Central Drugs Laboratory (CDL), Kasauli has cleared more than 21 lakh mRNA COVID-19 vaccine doses for stockpiling, the sources told ANI.
Read More
KTR inaugurates Ferring Pharmaceuticals facility in Hyderabad, company to
Updated : 3 years, 10 months ago IST
Hyderabad (Telangana) [India], April 25 (ANI): Telangana Minister for Industries and Commerce KT Rama Rao on Monday inaugurated the facility of the Ferring Pharmaceuticals in Hyderabad, a Switzerland-headquartered global biopharmaceutical group, and said that the company will focus on "devel
Read More
Bharat Serums and Vaccines to invest Rs 200 crore in Genome Valley
Updated : 3 years, 11 months ago IST
Hyderabad (Telangana) [India], April 12 (ANI): Biopharmaceutical firm Bharat Serums and Vaccines Limited (BSV) on Tuesday said it would invest Rs 200 crore in the development of injectable and vaccine manufacturing facility at Genome Valley, India's first organised cluster for Life Sciences
Read More
PanOptix Trifocal Intraocular Lens Surpasses One Million Implants Worldwid
Updated : 3 years, 11 months ago IST
New Delhi [India], April 8 (ANI/PNN): Alcon, the global leader in eye care dedicated to helping people see brilliantly, today announced AcrySof® IQPanOptix® Trifocal Intraocular Lens (IOL) has surpassed more than one million implants worldwide. To mark this milestone, Alcon is laun
Read More